LONDON–(BUSINESS WIRE)–  Re: Economic Master Issuer PLC   GBP  400,000,000.00   MATURING: 25-Apr-2075   ISIN: XS2710130605     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 25-Aug-2026 TO 25-Sep-2026 HAS BEEN FIXED AT 4.24 PCT   DAY BASIS: ACTUAL/365(PROP)   INTEREST PAYABLE VALUE 25-Sep-2026 WILL AMOUNT TO: GBP       2.36 PER GBP   655.00 DENOMINATION  

ANTWERP, Belgium–(BUSINESS WIRE)–REGULATED INFORMATION In accordance with Article 14 of the Belgian Transparency law of 2 May 2007, Azelis Group NV (Brussels:AZE) announces that on 15 September 2026 and 17 September 2026, it has received two transparency notifications from UBS Group AG. 1. Summary of the notifications UBS Group AG reported in its notification dated 15 September 2026, that on 11 September 2026, following an acquisition of equivalent financial instruments, UBS Group AG (taking

ANTWERPEN, België–(BUSINESS WIRE)–GEREGULEERDE INFORMATIE In overeenstemming met artikel 14 van de Belgische Transparantiewet van 2 mei 2007 maakt Azelis Group NV (Brussels:AZE) bekend dat het twee transparantiekennisgevingen heeft ontvangen van UBS Group AG op 15 september 2026 en 17 september 2026. 1. Samenvatting van de kennisgevingen UBS Group AG heeft in een kennisgeving gedateerd op 15 september 2026 gemeld dat op 11 september 2026, na een verwerving van gelijkgestelde financiële instru

PARIS–(BUSINESS WIRE)–Regulatory News: ALIKO Scientific (Ikonisys SA – Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces that its wholly-owned US subsidiary has reached a settlement resolving an existing dispute, pursuant to which it will receive a payment of USD 2 million. The related proceedings have been dismissed. About ALIKO SCIENTIFIC Headquartered in Paris, ALIKO SCIENTIFIC is the parent company of an internation

PARIS–(BUSINESS WIRE)–Regulatory News: ALIKO Scientific (Ikonisys SA – Euronext Growth Paris : ALIKO), groupe international des sciences de la vie dédié au diagnostic oncologique intégré, annonce que sa filiale américaine détenue à 100 % a conclu un accord transactionnel mettant fin à un litige en cours, aux termes duquel elle percevra la somme de 2 millions de dollars américains. Les procédures judiciaires relatives à ce litige ont été closes. À propos d’ALIKO SCIENTIFIC (Ikonisys SA) Basée

LIESTAL, Switzerland–(BUSINESS WIRE)–Curatis Holding AG (SIX:CURN, “Curatis”) reports net sales from goods and services of CHF 7.9m for the first half of 2026, up 51% (H1 2025: CHF 5.2m), with the loss for the period narrowing to CHF -0.4m (H1 2025: CHF -1.2m) and cash and cash equivalents rising to CHF 3.6m (31 December 2025: CHF 1.9m). Curatis also advanced its corticorelin (C-PTBE-01) program on multiple levels, including an exclusive Japan licence with Neupharma and continued manufacturin

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.